zSpace Announces Second Quarter 2025 Earnings and Conference Call Information

zSpace Announces Second Quarter 2025 Earnings and Conference Call Information GlobeNewswire July 31, 2025 SAN JOSE, Calif., July 31, 2025 (GLOBE NEWSWIRE) — zSpace (Nasdaq: ZSPC) (“zSpace” or the “Company”), a leader in immersive learning, announced today that it plans to release financial results for the second quarter ended June 30, 2025, on Thursday, August […]

Synergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call Information

Synergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call Information GlobeNewswire July 31, 2025 WESTBROOK, Maine, July 31, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a fast-growing consumer health and wellness company, announced today that it plans to release financial results for the second quarter ended June

El Pollo Loco Holdings, Inc. Announces Second Quarter 2025 Financial Results

El Pollo Loco Holdings, Inc. Announces Second Quarter 2025 Financial Results GlobeNewswire July 31, 2025 COSTA MESA, Calif., July 31, 2025 (GLOBE NEWSWIRE) — El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13-week period ended June 25, 2025. Highlights for the second quarter ended June 25, 2025 compared to the

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering GlobeNewswire July 31, 2025 HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) — NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate

Orchestra BioMed Announces Proposed Public Offering

(NasdaqGM:OBIO), NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced today that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock

Aimco Announces Second Quarter 2025 Earnings Date

Apartment Investment and Management Company (“Aimco”) (NYSE: AIV) announced today that it plans to report 2025 second quarter results on Monday, August 11, 2025, after the market closes. Aimco's earnings release will be available in the Investor Relations section of its website at investors.aimco.com. https://mma.prnewswire.com/media/2401790/Aimco_Logo.jpg About Aimco Aimco is a diversified real estate company primarily

Orchestra BioMed Announces Proposed Public Offering

Orchestra BioMed Announces Proposed Public Offering GlobeNewswire July 31, 2025 NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced today that it has commenced an underwritten public offering of shares of

StoneX Completes Acquisition of R.J. O’Brien, Becoming the Largest Non-Bank FCM in the United States and Enhancing Global Multi-Asset Capabilities

(NASDAQ:SNEX), NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) (“StoneX” or the “Company”), today announced the successful completion of its previously announced acquisition of R.J. O'Brien (“RJO”), the oldest independent futures brokerage in the United States. This transformative acquisition makes StoneX the largest non-bank Futures Commission Merchant (“FCM”) in the

Solesence Reports Second Quarter 2025 Financial Results

(NASDAQ:SLSN), ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) — Solesence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025. Recent Highlights and Accomplishments Joined broad-market Russell 3000(R) and small-cap Russell 2000(R) Indexes Amended loan agreements to

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

(NasdaqGM:OBIO),(NasdaqGM:LGND),(NYSE:MDT), • Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an additional $20 million in a secured subordinated promissory note

Scroll to Top